Sequoia Financial Advisors, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1599900
Akron, OH
Position in TEVA
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$5,111,364
+$806,132 QoQ
Shares Held
169,700
+23.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Sequoia Financial Advisors, LLC holds $18,289,856 across 14 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
169,700 | $5,111,364 | |
| 2 | ZTS |
Zoetis Inc.
|
20,927 | $2,473,780 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
163,060 | $2,258,381 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
98,936 | $1,832,294 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,424 | $1,437,383 | |
| 6 | VTRS |
Viatris Inc
|
99,279 | $1,341,259 | |
| 7 | HLN |
Haleon plc
|
102,062 | $1,021,640 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
4,849 | $638,807 |
All Filings in TEVA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,111,364 | 169,700 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $4,305,232 | 137,944 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,746,149 | 135,948 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,233,990 | 133,293 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,040,398 | 132,752 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,508,085 | 113,797 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $2,025,087 | 112,380 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,813,093 | 111,575 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,562,668 | 110,749 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,151,928 | 110,338 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,073,050 | 105,201 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $785,936 | 104,374 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $975,385 | 110,213 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $932,520 | 102,250 | Shares | Sole | 2023-02-10 | |
| 2022-03-31 | $119,159 | 12,690 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $87,925 | 10,977 | Shares | Sole | 2022-02-22 | |
| 2020-12-31 | $104,191 | 10,797 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $125,944 | 14,025 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||